Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu Meng

Showing results (331-340 of 372) with videos related to

Pageof 38
Sort By:
Ebiomedicine|June 25, 2024
Optimal use of β-lactams in neonates: machine learning-based clinical decision support systemBo-Hao Tang, Bu-Fan Yao, Wei Zhang, et al.
The Journal of Clinical Investigation|January 26, 2013
Blockade of NOX2 and STIM1 signaling limits lipopolysaccharide-induced vascular inflammationRajesh Kumar Gandhirajan, Shu Meng, Harish C Chandramoorthy, et al.
Plos One|January 23, 2016
MicroRNA-134 Contributes to Glucose-Induced Endothelial Cell Dysfunction and This Effect Can Be Reversed by Far-Infrared IrradiationHsei-Wei Wang, Shu-Han Su, Yen-Li Wang, et al.
Journal of Vascular Research|January 26, 2017
Dysregulation of Vascular Endothelial Growth Factor Receptor-2 by Multiple miRNAs in Endothelial Colony-Forming Cells of Coronary Artery DiseaseShu-Han Su, Chun-Hsien Wu, Ya-Lin Chiu, et al.
Inflammation|February 6, 2024
The Angiotensin II Receptor Neprilysin Inhibitor LCZ696 Inhibits the NLRP3 Inflammasome By Reducing Mitochondrial Dysfunction in Macrophages and Alleviates Dextran Sulfate Sodium-induced Colitis in a Mouse ModelHsiao-Wen Chiu, Chun-Hsien Wu, Wen-Yu Lin, et al.
Frontiers in Immunology|June 7, 2022
Repositioning of the Angiotensin II Receptor Antagonist Candesartan as an Anti-Inflammatory Agent With NLRP3 Inflammasome Inhibitory ActivityWen-Yu Lin, Lan-Hui Li, Ya-Yun Hsiao, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 14, 2014
Impact of renal dysfunction on clinical outcome in patients with low risk of atrial fibrillationWen-Yu Lin, Yenn-Jiang Lin, Fa-Po Chung, et al.
British Journal of Clinical Pharmacology|April 4, 2025
Machine learning approach for dosage individualization of azithromycin in children with community-acquired pneumoniaBo-Hao Tang, Shu-Meng Fu, Li-Yuan Tian, et al.
Plos One|July 20, 2018
Small molecule disruption of G protein βγ subunit signaling reprograms human macrophage phenotype and prevents autoimmune myocarditis in ratsVengadeshprabhu Karuppagounder, Anamika Bajpai, Shu Meng, et al.
The Journal of Antimicrobial Chemotherapy|September 23, 2025
Population pharmacokinetics and dosing optimization of cefoselis in paediatric patients with haematological malignanciesJing-Rui Liu, Shu-Meng Fu, Totsapol Jirasomprasert, et al.
Pageof 38

Showing results (331-340 of 372) with videos related to

Sort By:
Pageof 38
Ebiomedicine|June 25, 2024
Optimal use of β-lactams in neonates: machine learning-based clinical decision support systemBo-Hao Tang, Bu-Fan Yao, Wei Zhang, et al.
The Journal of Clinical Investigation|January 26, 2013
Blockade of NOX2 and STIM1 signaling limits lipopolysaccharide-induced vascular inflammationRajesh Kumar Gandhirajan, Shu Meng, Harish C Chandramoorthy, et al.
Plos One|January 23, 2016
MicroRNA-134 Contributes to Glucose-Induced Endothelial Cell Dysfunction and This Effect Can Be Reversed by Far-Infrared IrradiationHsei-Wei Wang, Shu-Han Su, Yen-Li Wang, et al.
Journal of Vascular Research|January 26, 2017
Dysregulation of Vascular Endothelial Growth Factor Receptor-2 by Multiple miRNAs in Endothelial Colony-Forming Cells of Coronary Artery DiseaseShu-Han Su, Chun-Hsien Wu, Ya-Lin Chiu, et al.
Inflammation|February 6, 2024
The Angiotensin II Receptor Neprilysin Inhibitor LCZ696 Inhibits the NLRP3 Inflammasome By Reducing Mitochondrial Dysfunction in Macrophages and Alleviates Dextran Sulfate Sodium-induced Colitis in a Mouse ModelHsiao-Wen Chiu, Chun-Hsien Wu, Wen-Yu Lin, et al.
Frontiers in Immunology|June 7, 2022
Repositioning of the Angiotensin II Receptor Antagonist Candesartan as an Anti-Inflammatory Agent With NLRP3 Inflammasome Inhibitory ActivityWen-Yu Lin, Lan-Hui Li, Ya-Yun Hsiao, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 14, 2014
Impact of renal dysfunction on clinical outcome in patients with low risk of atrial fibrillationWen-Yu Lin, Yenn-Jiang Lin, Fa-Po Chung, et al.
British Journal of Clinical Pharmacology|April 4, 2025
Machine learning approach for dosage individualization of azithromycin in children with community-acquired pneumoniaBo-Hao Tang, Shu-Meng Fu, Li-Yuan Tian, et al.
Plos One|July 20, 2018
Small molecule disruption of G protein βγ subunit signaling reprograms human macrophage phenotype and prevents autoimmune myocarditis in ratsVengadeshprabhu Karuppagounder, Anamika Bajpai, Shu Meng, et al.
The Journal of Antimicrobial Chemotherapy|September 23, 2025
Population pharmacokinetics and dosing optimization of cefoselis in paediatric patients with haematological malignanciesJing-Rui Liu, Shu-Meng Fu, Totsapol Jirasomprasert, et al.
Pageof 38